Regulating software as a medical device

CANBERRA: With huge technological advances being made in the delivery of health products and services, it is crucial to keep an eye on any regulatory movement. This is particularly important in the case of software, which is both incorporated into medical devices and may in and of itself hold the status of medical device.

The Therapeutic Goods Administration (TGA) has recently published guidance on the regulation of software as a medical device (SaMD) in Australia.

The regulation of SaMD products in Australia is based on risk. The level of oversight by the TGA varies according to the risk the TGA assesses a product poses to patients and healthcare professionals.

Recently, concerns have been raised that many SaMD products have been classified as low risk, even though their potential risk for patients and healthcare professionals may be higher. To address this issue, the TGA will soon be consulting on changes to the Therapeutic Goods Regulations.

The TGA is also currently reviewing the regulatory framework for SaMD in Australia. The purpose of the review is to ensure the framework meets international standards, and extends beyond health risks to patients and healthcare professionals to address potential harms to the wider public.

In particular, the TGA is seeking to ensure the regulatory framework is harmonious with technical documents published by the International Medical Device Regulators Forum (of which the TGA is a founding member).